CBS Evening News for Wednesday, Nov 17, 2010
View other clips in this broadcast →
Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Washington: Wyatt Andrews) The debate over whether Medicare should pay for the drug Provenge for prostate cancer patients examined; details given about how the costly drug is made to attack the cancer and what Medicare will likely decide. [Cancer patient Sal CICERO, patient advocate Jim KIEFERT, Dendreon Corp. president/CEO Dr. Mitchell GOLD- talk about the drug.] The high cost per patient of Provenge and other biologic drugs outlined on screen. [Express Scripts CMO Dr. Steven MILLER- comments on reining in cost.]
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.